Latest News

Marcus Hughes, MD, left, and Samuel Wilkinson, MD, right, are first and senior authors, respectively, of a paper in Psychiatric Times that examines rapid antidepressant treatments and their relationship with suicide risk.

Sophie Holmes, PhD, assistant professor of psychiatry is senior author of a paper in Neuropsychopharmacology that argues psychiatric symptoms such as depression, anxiety, psychosis, and changes in motivation should be viewed as integral features of neurodegenerative diseases rather than secondary complications.

Eleven faculty in the Yale Department of Psychiatry were nominated for prestigious Yale School of Medicine teaching awards in Spring 2026.

Robert Rosenheck, MD, left, and Greg Rhee, PhD, right are senior and contributing authors, respectively, of a paper in Nature Mental Health that explains how machine learning can identify people with untreated substance use disorders.

Greg Rhee, PhD, associate professor adjunct in psychiatry, is senior author of a review in Psychotherapy & Psychosomatics that evaluated the long-term safety of ketamine and esketamine.

College students are getting ready to start the semester. Stress is normal, but Gerard Sanacora, MD, PhD, explained on WTNH-TV News 8 how to know if what students are feeling may be something more serious.

From left, Morgan Hardy, MD, MPH; Songjun William Li, MD, PhD; and Samuel Wilkinson, MD, are co-authors of a paper in Focus that proposes a framework for interventional psychiatrists who seek to incorporate cognitive-behavioral therapy into ketamine-based treatment programs.

The Yale Department of Psychiatry honored 22 residents at the annual Yale Psychiatry Residency Program commencement ceremony June 17 at the New Haven Lawn Club.

For many Parkinson’s disease patients, depression is the hardest part. A new Yale study may finally explain why standard antidepressants aren’t effective.